Scientists pinpoint how non-alcoholic fatty liver disease increases risk of vascular diseases

Credit: Pixabay/CC0 Public Domain

A team of researchers led by NTU scientists have discovered why patients with non-alcoholic fatty liver disease (NAFLD) are at higher risk of cardiovascular disease, thus shedding light on why the leading cause of mortality in NAFLD patients is cardiovascular complications instead of liver damage.

The researchers found that NAFLD prompts the over-production of a class of proteins that cause inflammation and damage to their blood vessels.

NAFLD is a general term for affecting patients who drink little to no alcohol. It is mainly characterized by having too much fat stored in and can lead to and liver cancer.

The team found that the of patients contained higher levels of a class of proteins called chemokines—up to three times higher than in healthy individuals.

Chemokines are strong attractants of immune cells, and are tasked with drawing immune cells to sites of infections to combat foreign particles. However, when abnormally high levels of immune cells are recruited into a blood vessel, it becomes harmful.

The researchers discovered that the higher level of chemokines in fatty liver disease patients was attracting T cells into blood vessel walls. These T cells then cause inflammation of blood vessels, damaging them.

Higher levels of damage and inflammation can lead to leakiness in the blood vessels, impairing blood vessels' integrity over time and increasing the risk of blood clot formation.

Understanding how NAFLD affects heart health can help to inform clinical care for patients, the researchers say.

The research team, led by Nanyang Assistant Professor Christine Cheung from NTU's Lee Kong Chian School of Medicine (LKCMedicine), found a higher level of blood vessel damage in NAFLD patients, which increases the risks of blood clots and cardiovascular diseases.

Asst Prof Cheung says that "the growing prevalence of fatty liver disease globally is a concern. In Singapore, one in three is likely to develop non-alcoholic fatty liver disease over the next 10 years. These patients are at increased risk of developing vascular diseases, such as coronary artery disease and cerebrovascular disease. The good news is that liver disease, at its early stages, is reversible."

The team published their findings in EMBO Reports in April.

More information: Chun‐Yi Ng et al, Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease, EMBO reports (2022). DOI: 10.15252/embr.202154271

Journal information: EMBO Reports

Citation: Scientists pinpoint how non-alcoholic fatty liver disease increases risk of vascular diseases (2022, May 25) retrieved 7 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

More cardiovascular disease found in lean people with NAFLD than in those who are overweight


Feedback to editors